Cloverfields Capital Group, LP Novo Nordisk A S Transaction History
Cloverfields Capital Group, LP
- $277 Million
- Q2 2024
A detailed history of Cloverfields Capital Group, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 26,749 shares of NVO stock, worth $2.95 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
26,749
Previous 26,510
0.9%
Holding current value
$2.95 Million
Previous $3.4 Million
12.2%
% of portfolio
1.38%
Previous 1.25%
Shares
15 transactions
Others Institutions Holding NVO
# of Institutions
1,959Shares Held
321MCall Options Held
5.16MPut Options Held
4.96M-
Jennison Associates LLC21.2MShares$2.34 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.61 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.56 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.47 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.38 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $249B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...